Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.88%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 5.08Close
$ 2.82 - $ 16.95 52-Week Range
Ticker Information
Ticker
EKSOCompany Name
EKSO BIONICS HOLDINGS INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQEKSO BIONICS HOLDINGS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EKSO - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 275K | 1.88% | $ 14.65M |
| 3/31/2025 | $ 284K | 1.62% | $ 17.54M |
| 12/31/2024 | $ 269K | 1.5% | $ 17.93M |
| 9/30/2024 | $ 276K | 1.56% | $ 17.68M |
| 6/30/2024 | $ 261K | 1.44% | $ 18.16M |
| 3/31/2024 | $ 248K | 1.38% | $ 17.91M |
| 12/31/2023 | $ 302K | 1.65% | $ 18.28M |
| 9/30/2023 | $ 318K | 1.87% | $ 16.98M |
| 6/30/2023 | $ 288K | 1.83% | $ 15.71M |
| 3/31/2023 | $ 256K | 1.77% | $ 14.47M |
Key Performance Insights, Last 5 Years
- EKSO BIONICS HOLDINGS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 1.75%.
- Over the past 5 years, EKSO BIONICS HOLDINGS INC's average Int. Exp. % has been 1.41%.
- The median Int. Exp. % for EKSO BIONICS HOLDINGS INC during this period was 1.47%
- EKSO BIONICS HOLDINGS INC reached its highest Int. Exp. % over the past 5 years at 1.88%.
- The lowest Int. Exp. % recorded by EKSO BIONICS HOLDINGS INC in the same timeframe 0.88%
EKSO BIONICS HOLDINGS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for EKSO BIONICS HOLDINGS INC is calculated as follows: Int. Exp. [ $ 181K ] / Revenues [ $ 10.35M ]
(=) Int. Exp. % [ 1.75% ] EKSO - Interest Expense Margin, Last 5 years
0.88%
Minimum
Jun 30, 2022
1.88%
Maximum
Jun 30, 2025
1.41%
Average
1.47%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |